Related Experiment Videos
Variations among non-sedating antihistamines: are there real differences?
1Institute of Biomedicine, Department of Pharmacology and Toxicology, University of Helsinki, Finland.
European Journal of Clinical Pharmacology
|May 21, 1999
Summary
Modern non-sedating antihistamines offer improved allergy relief with fewer central nervous system effects. However, individual sensitivity and drug interactions can still cause sedation, and some carry cardiac risks.
Area of Science:
- Pharmacology
- Allergy and Immunology
Background:
- Older antihistamines often caused significant central nervous system (CNS) sedation and antimuscarinic side effects.
- Newer non-sedating H1 receptor antagonists (antihistamines) were developed to minimize these effects.
- Despite improvements, some newer antihistamines may still cause sedation and possess cardiotoxic potential.
Purpose of the Study:
- To review the properties of modern non-sedating H1 receptor antagonists.
- To discuss their efficacy in treating allergic conditions.
- To highlight potential central effects and cardiotoxicity risks.
Main Methods:
- Review of available literature on H1 receptor antagonists.
- Analysis of clinical studies and pharmacological data.
- Comparison of sedative and cardiotoxic profiles of various antihistamines.
Main Results:
- Most modern antihistamines penetrate the brain poorly, reducing central effects.
- Individual patient factors and drug interactions can lead to unexpected sedation.
- Certain antihistamines (astemizole, terfenadine) carry a risk of cardiac dysrhythmias.
Conclusions:
- Non-sedating antihistamines provide effective allergy treatment with a better safety profile than older drugs.
- Caution is advised regarding potential sedation and cardiac risks, especially with specific drug interactions.
- Glucocorticoids are preferred for long-term itching management over sedating antihistamines.